From eczema and psoriasis to arthritis and Parkinson’s, the appearance of our hands can tell us a lot about the state of our ...

Understand how psoriatic arthritis increases heart disease risk through inflammation. Learn management tips for heart health, from lifestyle changes to medication discussions.

Tildrakizumab is an interleukin-23 antagonist approved under the brand name Ilumya for the treatment of plaque psoriasis.

The FDA has accepted for review the sNDA for deucravacitinib for the treatment of adults with active psoriatic arthritis.

“This study suggests that subclinical synovitis is more prevalent among patients with psoriasis without musculoskeletal involvement than healthy controls, suggesting that imaging may help identify ...

Princeton, New Jersey Tuesday, July 22, 2025, 12:00 Hrs [IST] ...

Bristol Myers Squibb said the U.S. Food and Drug Administration has accepted its application seeking expanded approval of its plaque psoriasis drug Sotyktu for the treatment of adults with active ...

Many people with psoriatic arthritis will experience symptoms in their feet. This can lead to swollen toes, pitted nails, ...

Psoriatic arthritis (PsA) is less common among Black people compared to other races, but differences in prevalence may also ...

Psoriatic arthritis often affects the fingers, wrists, knees, ankles, or toes. But some people may also experience lower back pain and stiffness. Learn more.

Psoriatic and rheumatoid arthritis cause similar symptoms, but key differences can help you and your healthcare provider tell them apart.

Metabolic syndrome is common in psoriatic arthritis and is a known risk factor for worse symptoms and poor treatment outcomes. This study sought to explore the syndrome's role in a more precisely ...